Pierrick Gouel
Pierrick Gouel is an expert in Radiotherapy at Centre Henri Becquerel (France). Pierrick Gouel has authored 44 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 112 (community average: 125). How the SLR is computed.
LeadR Profile
Radiotherapy
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2014 - 2026
Number : 44
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Magnetic resonance imaging and radiotherapy: Precision begins with imaging. PMID 42933262 — radiotherapy, tomography, magnetic resonance imaging, therapeutics, tissues | Cancer Radiother | 2026 | 0 |
| Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer. PMID 40015915 — radiotherapy, cells, lung, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, chemoradiotherapy, nuclear medicine | J Nucl Med | 2025 | 0 |
| Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial. PMID 39134086 — radiotherapy, cells, lung, paclitaxel, induction chemotherapy, neoplasms, radiotherapy, conformal, carcinoma, non-small-cell lung, drug therapy, drug-related side effects and adverse reactions, lung neoplasms, vinorelbine, chemoradiotherapy, small cell lung carcinoma, therapeutics, carboplatin, chemotherapy | Lancet Oncol Top journal | 2024 | 28 |
| Evaluation of the capability and reproducibility of RECIST 1.1. measurements by technologists in breast cancer follow-up: a pilot study. PMID 37277412 — natural science disciplines, research design, pilot projects, therapeutics, breast neoplasms, classification, pilots, response evaluation criteria in solid tumors | Sci Rep | 2023 | 3 |
| Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers. PMID 36980806 — head and neck neoplasms, oropharynx, radiotherapy, positron emission tomography computed tomography | Cancers (Basel) | 2023 | 4 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map